MMP-2 is up-regulated in EC exposed to inflammatory cytokines such as interleukin-1-beta and growth factors including nerve growth factor, where in vivo, it promotes capillary invasion and so is probably increased in active stroke regions undergoing remodelling [22,23]. This evidence concerns the gene NGF and stroke disorder.